Navigation Links
CEL-SCI Presents Data at American College of Rheumatology Conference Which Suggests that CEL-2000 Has Potential to Slow Damage Caused by Rheumatoid Arthritis
Date:10/19/2009

, as indicated by deformation of foot joints (Arthritic Index (AI) score), of untreated, and CEL-2000 and Enbrel treated groups, was compared. In another study CEL-2000 was administered 5 times over a 70 day period and the animals were monitored for another 20 days for a total study period of 90 days. In each case, CEL-2000 treatment proved effective at blocking the progression of disease with statistically significant reduction in AI score compared to the appropriate controls and was safe and well tolerated without any adverse effects. The protection mediated by CEL-2000 treatment was also demonstrated histologically by significant reductions in 1) inflammation, 2) cartilage destruction 3) bone resorption, and 4) pannus membrane formation in the synovial space compared to untreated controls.

The CEL-2000 treatment appeared to change the course of the immune response in the diseased and treated animals by limiting the development of a destructive Th17 and tumor necrosis factor alpha (TNF-alpha) directed autoimmune response. Analysis of serum levels of 21 cytokines/chemokines indicated reductions in the characteristic cytokine markers of rheumatoid arthritis, TNF-alpha and IL-17, and also IL-6, and MCP-1. A number of cytokine changes were also seen with Enbrel treatment, but to a lesser degree.

CEL-2000 may also offer a number of potential advantages over existing rheumatoid arthritis treatments, such as Enbrel. Data collected in the animal studies conducted with CEL-2000 demonstrated that CEL-2000 is an effective treatment against arthritis even with the administration of fewer treatments. CEL-2000 is also potentially a more disease-type specific therapy, should be significantly less expensive and finally, CEL-2000 could also be useful for patients who are not able to take or who may be unresponsive to existing anti-arthritis therapies.

Rheumatoid arthritis treatments comprise a $13 billion market. Enbrel, a leading rheuma
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Comprehensive Review of Cancer Immnunotherapies Published By CEL-SCI
2. CEL-SCI Corporation Announces Adoption of Shareholder Rights Plan
3. CEL-SCI Corporation Releases Letter to Shareholders
4. CEL-SCI CORPORATION Announces Results of 2008 Annual Meeting of Shareholders and Provides Update on Ground-breaking Activities Regarding Construction of Manufacturing Facility for Pivotal Phase III Cancer Trial
5. CEL-SCI Corporation Reports Second Quarter 2008 Financial Results
6. CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference
7. CEL-SCI Launches Study to Determine Long Lasting Beneficial Effects of its Rheumatoid Arthritis Vaccine
8. CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa
9. CEL-SCI Corporation Reports 2009 Second Fiscal Quarter Financial Results
10. CEL-SCI Expands Testing of Its Vaccine to Determine Efficacy Against More Virulent Strain of H1N1 Swine and Other Influenza Viruses
11. CEL-SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annual Aseptic Processing of Sterile Drug Products Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... OH (PRWEB) October 20, 2014 ... Assisted Living Center on Oct. 14. The $11 million ... and services, and a cooked-to-order kitchen with full-service restaurant ... Akron’s premier choice for first class Assisted Living apartments,” ... “Our residents deserve the highest quality of care and ...
(Date:10/20/2014)... National Teen Driver Safety Week is October 19-25, 2014 ... (Ohio AAP, http://www.ohioaap.org ) is joining the National Highway ... to talk to their teens and always set the rules ... the leading cause of death for U.S. teens. In 2012, ... 859 (42%) of those teen drivers were killed in crashes. ...
(Date:10/20/2014)... It’s hard to imagine what it’s like to live ... the world, it’s a reality. And while new shoes are ... to walk barefoot on rocky terrain or sewage-lined streets just ... friends. , Buckner International's Shoes for Orphan Souls ... October to encourage support for Air1 and while also providing ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Do you ... interventions? Here comes a wonderful app Metassessor for teachers, ... development company helped its client “Intervention Development LLC” ... The app is designed for iOS 4.3 or later ... This app is optimized for iPhone 5. It is ...
(Date:10/19/2014)... Recently, BambooIndustry.com, one of the most popular suppliers of ... bamboo deckings . Moreover, the company has launched a ... available at deeply discounted rates. , As is ... the significance of online business nowadays. Thus, BambooIndustry.com pays ... workers are striving to deliver both value and efficiency ...
Breaking Medicine News(10 mins):Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2
... prizes of $1 million each for outstanding achievement, announced the ... who donate 10% of their prize money towards 20 Tel ... a ceremony on May 19, 2008, at Tel Aviv University ... Israel, Mr. Shimon Peres. , Accepting the award, Vice President ...
... Minn., Feb. 26 Acuo Technologies, a market,leading ... imaging,industry for archiving, collaboration and migration services, is ... for Imaging,(XDS-I) solution, One of the most ... to,share clinical content. Healthcare IT solutions today must ...
... eWorld Companies, Inc.,(Pink Sheets: EWRL) announced today that ... a long-term strategic alliance with,the Hemophilia Foundation of ... eWorld and HFSC will engage in a series ... advertise,HFSC and its events and activities on its ...
... FRANCISCO, Feb. 26 VIA Pharmaceuticals,Inc. (Nasdaq: VIAP ... for the treatment of cardiovascular disease, announced today that,James ... VIA,will present a company update at the Susquehanna Second ... at 1:30 p.m. ET at the W,Hotel in New ...
... Inc.,(OTC Bulletin Board: EMED), a leading provider of ... healthcare industry,has signed a distribution agreement with Southwood ... product line of MedCom USA.,MedCom,s products offer real-time ... include Credit/Debit, Easy Pay and Check,Guarantee/EFT all delivered ...
... N.J., Feb. 26 You know that the ... young women. Is there a,theoretical basis for exploring ... HPV Vaccination" a 3-part CME Webcast, assesses this,and ... is an online,offering from Sexuality, Reproduction and Menopause ...
Cached Medicine News:Health News:Al Gore, Tom Stoppard and Amos Oz Are 2008 Dan David Prize winners 2Health News:Al Gore, Tom Stoppard and Amos Oz Are 2008 Dan David Prize winners 3Health News:Acuo Technologies(R) Announces a Fully Integrated XDS-I Solution 2Health News:eWorld Companies, Inc. Establishes Strategic Alliance With Hemophilia Foundation of Southern California 2Health News:eWorld Companies, Inc. Establishes Strategic Alliance With Hemophilia Foundation of Southern California 3Health News:MedCom USA Signs Southwood Medical Marketing to Distribute MedCom System 2Health News:MedCom USA Signs Southwood Medical Marketing to Distribute MedCom System 3Health News:MedCom USA Signs Southwood Medical Marketing to Distribute MedCom System 4Health News:Experts Delve Into Issues of HPV Vaccination 2
(Date:10/19/2014)... 2014  Henry Schein, Inc. (NASDAQ: HSIC ... and services to office-based dental, animal health and medical ... Dental Supply, Inc., a leading full-service provider of dental ... Schein,s entrance into Japan , the ... to 28 the number of countries in which the ...
(Date:10/17/2014)... 2014  Training market researchers to spot and ... in today,s highly competitive global marketplace. As resources ... effectively and efficiently produce high performing analysts, regardless ... Effective training programs can help these ... internal clients by developing analysts who can drive ...
(Date:10/17/2014)... 2014 ... the addition of the  "China Interventional Cardiovascular ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... China impacted by accelerated ... concept, dietary habit, way of working and ...
Breaking Medicine Technology:Henry Schein Enters Japan With Investment in Iwase Dental Supply 2Henry Schein Enters Japan With Investment in Iwase Dental Supply 3Henry Schein Enters Japan With Investment in Iwase Dental Supply 4Henry Schein Enters Japan With Investment in Iwase Dental Supply 5Effective Training Programs for Market Research Groups can Boost Overall Organizational Success 2China Interventional Cardiovascular Device Industry Report 2014-2017 2China Interventional Cardiovascular Device Industry Report 2014-2017 3
It is available in a 5cc-balloon version with round tip and two opposing eyes, and a 30cc-balloon version with two staggered eyes. BARDEX Silicone-Elastomer Foley Catheters are also available in kits...
All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open packages. Intended for one-time use....
The BARDEX I.C. Catheter represents Bard's newest technology in providing protection against NUTI....
Used to provide bladder drainage by percutaneous placement of a Malecot catheter. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: